Dermatology · Scottsdale, AZ
NPI
1073740304
Since 2009
Specialty
Dermatology
Code 207N00000X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
8390 E Via de Ventura Ste F110
Scottsdale, AZ, 85258
Phone (917) 983-0758
Medicare paid, 2024
$230K
3,441 services
Medicare patients, 2024
1,187
Average age 75
Drug cost, 2024
$1.4M
1,898 prescriptions
Company payments, 2025
$4,884
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lindsey A Bordone was code 99214 (office e&m - established), 900 times for 687 patients. In total Lindsey A Bordone billed 3,441 services in 38 codes, and Medicare paid $230K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 900 | 687 | $106.54 | $96K |
| 17003 Destruction Skin Lesion | Office | 599 | 139 | $6.27 | $3,755 |
| 99213 Office E&M - Established | Office | 498 | 419 | $77.71 | $39K |
| 17000 Destruction Skin Lesion | Office | 263 | 221 | $50.94 | $13K |
| 17110 Destruction Skin Lesion | Office | 244 | 213 | $99.54 | $24K |
| 11102 Skin Biopsy | Office | 169 | 153 | $82.50 | $14K |
| 99203 Office E&M - New | Office | 125 | 125 | $90.92 | $11K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 70 | 32 | $0.73 | $51.05 |
| 99212 Office E&M - Established | Office | 52 | 50 | $48.07 | $2,500 |
| 11900 Skin | Office | 36 | 26 | $40.61 | $1,462 |
| 11103 Skin Biopsy | Office | 30 | 20 | $48.94 | $1,468 |
| 99204 Office E&M - New | Office | 29 | 29 | $151.64 | $4,398 |
| 17111 Destruction Skin Lesion | Office | 26 | 18 | $115.41 | $3,001 |
| 17004 Destruction Skin Lesion | Office | 26 | 20 | $155.06 | $4,032 |
| 11104 Skin Biopsy | Office | 17 | 16 | $116.63 | $1,983 |
By year: 2022 $176K for 2,709 services; 2023 $204K for 2,964 services; 2024 $230K for 3,441 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lindsey A Bordone prescribed most often to Medicare patients was Minoxidil, with 467 prescriptions and refills. In total Lindsey A Bordone wrote 1,898 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Minoxidil Generic | 467 | 1,298 | 157 | $7,301 |
| Clobetasol Propionate Generic | 155 | 185 | 78 | $9,387 |
| Triamcinolone Acetonide Generic | 133 | 158 | 106 | $1,653 |
| Fluocinonide Generic | 118 | 135 | 79 | $4,109 |
| Ketoconazole Generic | 91 | 128 | 47 | $3,300 |
| Dupixent Pen Dupilumab | 90 | 90 | 11 | $324K |
| Hydrocortisone Generic | 70 | 75 | 51 | $587 |
| Doxycycline Hyclate Generic | 66 | 71 | 23 | $2,258 |
| Fluorouracil Generic | 64 | 67 | 59 | $3,648 |
| Tretinoin Generic | 44 | 56 | 27 | $2,442 |
| Metronidazole Generic | 35 | 42 | 13 | $1,285 |
| Ciclopirox Generic | 31 | 32 | 16 | $1,748 |
| Hydroxychloroquine Sulfate Generic | 30 | 62 | Under 11 | $882 |
| Finasteride Generic | 23 | 69 | Under 11 | $236 |
| Skyrizi Pen Risankizumab-Rzaa | 22 | 58 | Under 11 | $451K |
Brand drugs: 299 claims; generic drugs: 1,599 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lindsey A Bordone $4,884 ($4,884 in general payments such as food, travel and fees) from 4 companies. The largest payer was Pfizer Inc. with $4,698.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 5 | $4,698 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 4 | $98.67 |
| Galderma Laboratories, L.P. GALD.SW | 2 | $58.63 |
| Incyte Corporation INCY | 1 | $29.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.